These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9250352)

  • 41. Sjögren-Larsson syndrome: phenotypic variability in two brothers with a neurocutaneous disorder.
    Losito L; Gennaro L; De Rinaldis M; Cacudi M; Trabacca A
    Acta Neurol Belg; 2012 Jun; 112(2):205-8. PubMed ID: 22426667
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biochemical genetics of opossum aldehyde dehydrogenase 3: evidence for three ALDH3A-like genes and an ALDH3B-like gene.
    Holmes RS
    Biochem Genet; 2010 Apr; 48(3-4):287-303. PubMed ID: 20033765
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sjögren-Larsson syndrome is caused by a common mutation in northern European and Swedish patients.
    De Laurenzi V; Rogers GR; Tarcsa E; Carney G; Marekov L; Bale SJ; Compton JG; Markova N; Steinert PM; Rizzo WB
    J Invest Dermatol; 1997 Jul; 109(1):79-83. PubMed ID: 9204959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preterm birth in Sjögren-Larsson syndrome.
    Willemsen MA; Rotteveel JJ; van Domburg PH; Gabreëls FJ; Mayatepek E; Sengers RC
    Neuropediatrics; 1999 Dec; 30(6):325-7. PubMed ID: 10706028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hexokinase mutations that produce nonspherocytic hemolytic anemia.
    Bianchi M; Magnani M
    Blood Cells Mol Dis; 1995; 21(1):2-8. PubMed ID: 7655856
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genomic organization and expression of the human fatty aldehyde dehydrogenase gene (FALDH).
    Rogers GR; Markova NG; De Laurenzi V; Rizzo WB; Compton JG
    Genomics; 1997 Jan; 39(2):127-35. PubMed ID: 9027499
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts.
    Rizzo WB; Craft DA
    J Clin Invest; 1991 Nov; 88(5):1643-8. PubMed ID: 1939650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Update on Sjögren-Larsson syndrome.
    Lacour M
    Dermatology; 1996; 193(2):77-82. PubMed ID: 8884139
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phenotypic variability among adult siblings with Sjögren-Larsson syndrome.
    Lossos A; Khoury M; Rizzo WB; Gomori JM; Banin E; Zlotogorski A; Jaber S; Abramsky O; Argov Z; Rosenmann H
    Arch Neurol; 2006 Feb; 63(2):278-80. PubMed ID: 16476818
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carrier detection for Sjögren-Larsson syndrome.
    Kelson TL; Craft DA; Rizzo WB
    J Inherit Metab Dis; 1992; 15(1):105-11. PubMed ID: 1583866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isolation of animal cell mutants defective in long-chain fatty aldehyde dehydrogenase. Sensitivity to fatty aldehydes and Schiff's base modification of phospholipids: implications for Sj-ogren-Larsson syndrome.
    James PF; Zoeller RA
    J Biol Chem; 1997 Sep; 272(38):23532-9. PubMed ID: 9295289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genotype and phenotype variability in Sjögren-Larsson syndrome.
    Weustenfeld M; Eidelpes R; Schmuth M; Rizzo WB; Zschocke J; Keller MA
    Hum Mutat; 2019 Feb; 40(2):177-186. PubMed ID: 30372562
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes.
    Jansen GA; van den Brink DM; Ofman R; Draghici O; Dacremont G; Wanders RJ
    Biochem Biophys Res Commun; 2001 May; 283(3):674-9. PubMed ID: 11341778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel 4 bp deletion mutation in the FALDH gene segregating in a Turkish family with Sjögren-Larsson syndrome.
    Willemsen MA; Steijlen PM; de Jong JG; Rotteveel JJ; IJlst L; van Werkhoven MA; Wanders RJ
    J Invest Dermatol; 1999 May; 112(5):827-8. PubMed ID: 10233781
    [No Abstract]   [Full Text] [Related]  

  • 55. Sjögren-Larsson syndrome: optical coherence tomography and a novel mutation.
    Burgueño-Montañés C; García-Fernández M; Colunga-Cueva M; García-López A
    Arch Soc Esp Oftalmol; 2014 Dec; 89(12):504-7. PubMed ID: 24377952
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and molecular characterization and response to acitretin in three families with Sjögren-Larsson syndrome.
    Vural S; Vural A; Akçimen F; Bağci IS; Tunca C; Gündoğdu Eken A; Ruzicka T; Başak AN
    Int J Dermatol; 2018 Jul; 57(7):843-848. PubMed ID: 29704247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sjögren-Larsson syndrome due to a novel mutation in the FALDH gene.
    Botelho Gomes JM; Vieira AP; Navarro J; Maré R; Tavares P; Brito C
    Eur J Dermatol; 2011; 21(3):412-3. PubMed ID: 21524986
    [No Abstract]   [Full Text] [Related]  

  • 58. Sjogren-Larsson Syndrome: A case series of five members from an extended family with a novel mutation.
    Abidi KT; Kamal NM; Bakkar A AA; Alotaibi M; Asseri H; Bokari KA
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1487. PubMed ID: 32930514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel mutations and a severe neurological phenotype in Sjögren-Larsson syndrome patients from Iran.
    Kariminejad A; Barzgar M; Bozorgmehr B; Keshavarz E; Kariminejad MH; S'Aulis D; Rizzo WB
    Eur J Med Genet; 2018 Mar; 61(3):139-144. PubMed ID: 29183715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Sjögren-Larsson syndrome gene is close to D17S805 as determined by linkage analysis and allelic association.
    Pigg M; Jagell S; Sillén A; Weissenbach J; Gustavson KH; Wadelius C
    Nat Genet; 1994 Dec; 8(4):361-4. PubMed ID: 7894487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.